ANIP - ANI Pharmaceuticals Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript

ANI Pharmaceuticals, Inc. (ANIP) Q4 2021 Earnings Conference Call March 15, 2022, 08:30 ET Company Participants Judy DiClemente - IR Nikhil Lalwani - President, CEO & Director Stephen Carey - SVP, Finance & CFO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Gregory Fraser - Truist Securities Elliot Wilbur - Raymond James & Associates Presentation Operator Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. Fourth Quarter 2021 Earnings Results Call. [Operator Instructions] Please note this call may be recorded, and I will be standing by should you need any assistance. It is now my pleasure to turn today's program over to Judy DiClemente. Judy DiClemente Thank you, Britney. Welcome to ANI Pharmaceuticals' Q4 2021 Earnings Results Call. This is Judy DiClemente of In-Site Communications, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer; and Stephen Carey, Chief Financial

For further details see:

ANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call Transcript